FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy
The U.S. Food and Drug Administration announced that it recently approved Elevidys, the first gene therapy for the treatment of pediatric patients 4 through 5 years of age with Duchenne …
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy Read More